TAMPA, Fla.--(BUSINESS WIRE)--The clinical results of an IRB-approved prospective, multi-center, phase II, non-randomized pilot study utilizing the DRX9000™ will be presented at the 18th Annual Clinical Meeting of the American Academy of Pain Management in Las Vegas, NV September 27- 30, 2007. The study, authored by Dr. John Leslie of The Mayo Clinic, was designed to evaluate the effectiveness and safety of the DRX9000 in the treatment of chronic lower back pain. Patients enrolled in the study had suffered an overall average of ten years of chronic back pain. After two weeks of treatments on the DRX9000 there was a 50% reduction in pain scores and upon completion of the entire six week protocol an amazing success rate of 88.9% was documented. The patients also reported an improvement in their Oswestry Disability score. Abstracts and copies of the presentation will be made available following the release of the study data at the American Academy of Pain Management.
